Temporal delay of peak T-cell immunity determines Chlamydia pneumoniae pulmonary disease in mice.

Infection and Immunity
Chengming WangBernhard Kaltenboeck

Abstract

Severe chlamydial disease typically occurs after previous infections and results from a hypersensitivity response that is also required for chlamydial elimination. Here, we quantitatively dissected the immune and disease responses to repeated Chlamydia pneumoniae lung infection by multivariate modeling with four dichotomous effects: mouse strain (A/J or C57BL/6), dietary protein content (14% protein and 0.3% L-cysteine-0.9% L-arginine, or 24% protein and 0.5% L-cysteine-2.0% L-arginine), dietary antioxidant content (90 IU alpha-tocopherol/kg body weight versus 450 IU alpha-tocopherol/kg and 0.1% g L-ascorbate), and time course (3 or 10 days postinfection). Following intranasal C. pneumoniae challenge, C57BL/6 mice on a low-protein/low-antioxidant diet, but not C57BL/6 mice on other diets or A/J mice, exhibited profoundly suppressed early lung inflammatory and pan-T-cell (CD3delta(+)) and helper T-cell (CD45) responses on day 3 but later strongly exacerbated disease on day 10. Contrast analyses characterized severe C. pneumoniae disease as being a delayed-type hypersensitivity (DTH) response with increased lung macrophage and Th1 cell marker transcripts, increased Th1:Th2 ratios, and Th1 cytokine-driven inflammation. Results fro...Continue Reading

References

Jun 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·M K O'BanionD A Young
May 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·Y SagaE A Boyse
Sep 1, 1990·The Journal of Experimental Medicine·P Tekamp-OlsonA Cerami
Dec 1, 1989·The Journal of Experimental Medicine·D F FiorentinoT R Mosmann
May 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·P van den ElsenC Terhorst
Feb 1, 1988·European Journal of Immunology·J Van SnickR J Simpson
Jun 25, 1985·Nucleic Acids Research·L FransenA Van Vliet
Oct 31, 1988·Biochemical and Biophysical Research Communications·S OhnishiK Shimada
Oct 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·N G WatkinsH D Caldwell
Nov 1, 1985·Reviews of Infectious Diseases·J T GraystonC C Kuo
Dec 1, 1969·The Journal of Hygiene·S SowaW A Blyth
Oct 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·P W Gray, D V Goeddel
Aug 1, 1994·The Journal of Infectious Diseases·Z P YangC C Kuo
Mar 1, 1994·Microbial Pathogenesis·D Buzoni-GatelF Lantier
Oct 1, 1993·Microbial Pathogenesis·S S Kaukoranta-TolvanenK Laitinen
Oct 1, 1995·Clinical Microbiology Reviews·C C KuoJ T Grayston
Oct 1, 1996·The Journal of Infectious Diseases·L A JacksonJ T Grayston
Dec 10, 1996·Proceedings of the National Academy of Sciences of the United States of America·J ChanB R Bloom
Sep 24, 1998·Mammalian Genome : Official Journal of the International Mammalian Genome Society·O ShiW E O'Brien
Apr 26, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·M E RottenbergH Wigzell
Jan 17, 2002·Proceedings of the National Academy of Sciences of the United States of America·Koji YamamotoHidehiko Saito
Mar 21, 2002·Proceedings of the National Academy of Sciences of the United States of America·Jin HuangBernhard Kaltenboeck
Jun 4, 2002·Current Molecular Medicine·Sven BaumannPeter H Krammer
Nov 5, 2002·Annual Review of Immunology·Michelle L HermistonArthur Weiss
Jan 28, 2003·BioTechniques·Fred J DeGravesBernhard Kaltenboeck

❮ Previous
Next ❯

Citations

Oct 29, 2010·The Veterinary Journal·Petra ReinholdBernhard Kaltenboeck
Mar 13, 2015·Clinical and Vaccine Immunology : CVI·K Shamsur RahmanBernhard Kaltenboeck

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.